basal cell on the lip (malignant); she had a second cancer on the lip; bad scar on her lip underneath all the way up to the nose; biopsy of from her lip to her nose; cancer four times last year right above her lip; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), on 13Feb2021 as dose 2, single (Batch/Lot number: unknown) and on 16Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing), notes: Breast cancer started in 2001 or 2002.; "Partial mastectomy" (not ongoing), notes: Patient had partial mastectomy in her left breast in 2001 or 2003.; "lymphedema in left arm" (unspecified if ongoing), notes: lymphedema in left arm started at age 42; "Basal cell on the side of her nose" (unspecified if ongoing), notes: Basal cell on the side of her nose; "migraines" (unspecified if ongoing), notes: Stated that she had migraines before the vaccine and takes Immitrex. The patient's concomitant medications were not reported. Past drug history included: Immitrex for migraines. The following information was reported: BIOPSY (non-serious) with onset 23Mar2021, outcome "recovered with sequelae" (23Mar2021), described as "biopsy of from her lip to her nose"; SCAR (non-serious) with onset 18May2021, outcome "unknown", described as "bad scar on her lip underneath all the way up to the nose"; LIP AND/OR ORAL CAVITY CANCER (medically significant) with onset 2021, outcome "recovered with sequelae" (2021), described as "cancer four times last year right above her lip"; LIP NEOPLASM MALIGNANT STAGE UNSPECIFIED (medically significant) with onset 29Jun2021, outcome "recovered with sequelae" (2021), described as "she had a second cancer on the lip"; BASAL CELL CARCINOMA (medically significant), outcome "recovered" (Sep2021), described as "basal cell on the lip (malignant)". The patient underwent the following laboratory tests and procedures: Biopsy: (23Mar2021) Malignant, notes: biopsy of from her lip to her nose showed that the basal cell on her lips was malignant. Therapeutic measures were taken as a result of basal cell carcinoma.  Clinical course was reported as, Patient stated she has been disabled since age 42 and was on low income. Stated that she had underlying health conditions such as breast cancer which has nothing to do with this since the age of 42. Patient had cancer four times last year right above her lip and had four surgeries for basal cell on the lip last year. Patient had lasting effects from the biopsy of her lip of that it kept coming back in different surgeries and was aggressive. The second cancer on her lip was on 29Jun2021 and stated that the doctor had to open her up a second and third time. After the fourth time it was cleared in the margins and everywhere. Stated that this was in Aug or Sep2021. Patient stated that she has a bad scar from the surgeries. No other treatments other than that mentioned above.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.